Clinical Trial Update: A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and biomarker effects of RO7269162 in participants at risk for, or in the prodromal stage of, Alzheimer's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RO7269162

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Alzheimer's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING